Quantcast
Last updated on April 20, 2014 at 8:28 EDT

Latest Order theory Stories

2014-02-12 20:21:55

RIVER EDGE, N.J., Feb. 12, 2014 /PRNewswire/ -- Nephros, Inc. (OTCQB:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters, announced today that it has commenced its previously disclosed rights offering. On February 12, 2014, the Company will distribute to holders of its common stock and/or warrants one non-transferable subscription right for each share of common stock, and each share of common stock underlying a warrant,...

2013-11-29 16:21:34

RIVER EDGE, N.J., Nov. 29, 2013 /PRNewswire/ -- Nephros, Inc. (OTC Bulletin Board: NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters, announced today the appointment of Daron Evans to its Board of Directors. Mr. Evans replaces James S. Scibetta who will be leaving the Board effective December 31, 2013. Mr. Evans was also named a member of the Audit Committee. Mr. Evans is a life sciences executive with over 20 years of...

2013-11-21 16:22:15

Giving the Smaller Guy a chance often pays off big in the long term - for both parties. JACKSON CENTER, Pa., Nov. 21, 2013 /PRNewswire/ -- Today, Imperial Systems (Jackson Center, PA; isystemsweb.com) is one of the world's leading makers and suppliers of premium-quality dust-and-fume collection equipment: systems, filters, replacement parts, and comprehensive service. But its initial sale to a local manufacturer of overlay plate and other products that combat severe impact and...

2013-11-14 16:29:04

RIVER EDGE, N.J., Nov. 14, 2013 /PRNewswire/ -- Nephros, Inc. (OTC Bulletin Board: NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters, announced today financial results for the three and nine months ended September 30(th) 2013 and that the company entered into a bridge loan and security agreement with Lambda Investors LLC, an affiliate of Wexford Capital LP and the company's largest shareholder. Financial Performance for...

2013-05-08 16:28:24

RIVER EDGE, N.J., May 8, 2013 /PRNewswire/ -- Nephros, Inc. (OTC Bulletin Board:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters, announced today financial results for the three months ended March 31, 2013. Recent Highlights 42% increase in water filter sales Q1 2013 versus Q1 2012 Received EUR600,000 license payment from Bellco S.r.l Commenced Rights Offering and Temporary Reduction in Exercise Price for March...

2013-02-04 16:26:56

RIVER EDGE, N.J., Feb. 4, 2013 /PRNewswire/ -- Nephros, Inc. (OTC Bulletin Board: NEPH) and Chem-Aqua, Inc., a wholly owned water treatment subsidiary of NCH Corporation, announced today that the companies have signed a non-exclusive distributor agreement for Chem-Aqua to distribute Nephros's innovative ultrafilters in North America. Chem-Aqua is now beginning launch efforts, including scheduling training sessions and promoting ultrafilters to the hospital market. "The addition of Nephros...

2013-01-15 16:21:44

RIVER EDGE, N.J., Jan.15, 2013 /PRNewswire/ -- Nephros, Inc. (OTC Bulletin Board: NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters, announced that on January 15, 2013, Nephros received the scheduled payment of EUR600,000 from Bellco S.r.l. under the previously announced license agreement. Under the terms of the license agreement which became effective July 1, 2011, Nephros provided an exclusive license to Bellco S.r.l....

2012-11-08 16:29:08

RIVER EDGE, N.J., Nov. 8, 2012 /PRNewswire/ -- Nephros, Inc. (OTC Bulletin Board: NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters, announced today financial results for the three and nine months ended September 30, 2012. Recent Highlights Year-to-date ultrafilter sales to our three target markets (Dialysis, Hospital and Military) of over $800,000 vs. approximately $600,000 for full year 2011 First shipment of over...

2012-04-19 06:27:18

Noveko® Filters Sold by Groupe BMR Dealers MONTREAL, April 19, 2012 /PRNewswire/ - Noveko International Inc. (TSX: EKO) (the "Company") is pleased to announce that its Noveko® antimicrobial air filters targeted to the residential market are now sold by the dealers of Groupe BMR, the second leading player in the Quebec renovation centres field. The filters incorporating Noveko's patented air filtration technologies thus mark their official breakthrough in the retail market....

2012-03-14 15:00:00

RIVER EDGE, N.J., March 14, 2012 /PRNewswire/ -- Nephros, Inc. (OTC Bulletin Board: NEPH), a medical device company developing and marketing filtration products for therapeutic applications, infection control, and water purification, today announced that the company has hired Shane Sullivan as Director of U.S. Sales. Mr. Sullivan has spent nearly two decades in a sales leadership role in the healthcare, life science and biopharmaceutical industry. Prior to joining Nephros, he led the sales...